Company Financials

SK Biopharmaceuticals Co. Ltd Financials

South Korean won

business SK Biopharmaceuticals Co. Ltd Company Profile

Main Stock Listing

KRX: 326030

Market Capitalization ₩9.625 Trillion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 39.98
Forward PE 35.28
Price to Sales TTM ₩14.45
Price to Book MRQ ₩13.95
Enterprise to Revenue 14.17
Enterprise to EBITDA 44.34

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 47.45%
Operating Margin 36.57%
Return on Assets TTM 13.73%
Return on Equity TTM 58.15%

Income Statement

Revenue TTM ₩675,405,561,856
Revenue per Share TTM ₩8624.41
Quarterly Revenue Growth 40.40%
Gross Profit TTM ₩641,577,713,664
EBITDA ₩178,800,842,860
Net Income to Common TTM ₩320,472,875,008
Diluted EPS TTM ₩3074.00
Quarterly Earnings Growth YoY 667.90%

Balance Sheet

Total Cash MRQ ₩256,164,773,888
Total Cash per Share MRQ ₩3271.03
Total Debt MRQ
Total Debt to Equity MRQ 7.16
Current Ratio MRQ 2.43
Book Value per Share MRQ ₩8806.93

Cash Flow

Operating Cash Flow TTM ₩146,181,931,008
Levered Free Cash Flow TTM ₩99,256,074,240

326030 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 78,313,250
Float Shares 28,070,601
Avg 10 Volume 137,136
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 64.16%
% Held by Institutions 13.80%

Stock Price Summary

Beta 0.77
Fifty Two Week Low ₩86900.00
Fifty Two Week High ₩144100.00
Fifty Two Week Change 10.17%
Day 50 MA ₩126016.00
Day 200 MA ₩106220.50

Dividends and Splits

Forward Annual Dividend Rate
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate
Trailing Annual Dividend Yield %
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date